mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0057 |
0.8 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0071 |
0.8 |
mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
-0.0069 |
0.9 |
mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.0069 |
0.9 |
mRNA |
BRD-K01737880 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.9 |
mRNA |
pitstop2 |
CTRPv2 |
pan-cancer |
AAC |
-0.0083 |
0.9 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
-0.0069 |
0.9 |
mRNA |
Fumonisin B1 |
CTRPv2 |
pan-cancer |
AAC |
0.0066 |
0.9 |
mRNA |
avrainvillamide |
CTRPv2 |
pan-cancer |
AAC |
-0.0073 |
0.9 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0054 |
0.9 |